Latest News about XNAS:GOVX
Recent news which mentions XNAS:GOVX
GeoVax Highlights New Study Demonstrating the Strength of Multi-Antigen COVID-19 Vaccine Candidates
April 16, 2025
Tickers
GOVX
Tickers
GOVX
Tickers
GOVX
Tickers
GOVX
GeoVax Receives USPTO Notice of Allowance for Marburg Hemorrhagic Fever Vaccine Patent
April 09, 2025
Tickers
GOVX
Tickers
GOVX
GeoVax Labs Announces $4.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
March 24, 2025
Tickers
GOVX
GeoVax to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update on March 27, 2025
March 17, 2025
Tickers
GOVX
Tickers
GOVX
GeoVax to Present at the 37th Annual Roth Conference
March 11, 2025
Tickers
GOVX
Tickers
GOVX
GeoVax Highlights the Critical Role of MVA-Based Vaccines in U.S. Biodefense Strategy
March 03, 2025
Tickers
GOVX
GeoVax Response to WHO's Third Declaration of Mpox as a Public Health Emergency of International Concern
February 27, 2025
Tickers
GOVX
GeoVax Highlights the Role of MVA-Based Vaccines in Advancing Public Health Preparedness
February 24, 2025
Tickers
GOVX
Tickers
GOVX
GeoVax Pledges Continued Support for Vaccine Innovation, Transparency, and Public Health
February 18, 2025
Tickers
GOVX
GeoVax to Present at the Emerging Growth Conference on February 19, 2025
February 17, 2025
Tickers
GOVX
GeoVax Congratulates Dr. Valerie Montgomery Rice on Receiving the 2025 Healthcare Champions Lifetime Achievement Award
February 11, 2025
Tickers
GOVX
GeoVax Anticipates Significant 2025 Progress With Catalyst-Rich Milestones Across Key Programs
February 05, 2025
Tickers
GOVX
GeoVax to Showcase Advancements in Vaccines & Immunotherapies at the 2025 BIO CEO & Investor Conference
February 04, 2025
Tickers
GOVX
GeoVax Announces Strategic Integration of AI in Support of President Trump's Stargate Initiative
February 03, 2025
Tickers
GOVX
Tickers
GOVX
GeoVax Advanced MVA Manufacturing Process: Aimed to Enhance Vaccine Supply Worldwide
January 27, 2025
Tickers
GOVX
Tickers
GOVX
GeoVax Achieves Significant Progress in Next-Generation COVID-19 Vaccine Development Throughout 2024
January 13, 2025
Tickers
GOVX
GeoVax to Review 2024 Progress at the Emerging Growth Conference on January 16, 2025
January 08, 2025
Tickers
GOVX
GeoVax to Review 2024 Progress at Biotech Showcase During J.P. Morgan Healthcare Week 2025
January 06, 2025
Tickers
GOVX
Tickers
GOVX
GeoVax to Raise Approximately $3.1 Million of Gross Proceeds in Offering Priced At-the-Market
July 11, 2024
Tickers
GOVX
GeoVax Provides First Half 2024 Business Update
July 09, 2024
Tickers
GOVX
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.